Court Invalidates Five Mallinckrodt Patents

Drug Industry Daily
A A
A federal court invalidated five Mallinckrodt Pharmaceuticals patents on its Inomax respiratory treatment system in response to the company’s own lawsuit against Praxair.

To View This Article:

Login

Subscribe To Drug Industry Daily